Cancer Diagnostics Market Report- Opportunities in Future with Different Segments

Growth Factors Driving the Market: The Growth of the Cancer Diagnostics Market is driven mainly by increasing incidence of cancer and growth in the number of private diagnostic laboratories.

In an attempt to detect cancer in the early stages and bring down the mortality rate, governments in developed countries and primary care doctors are recommending cancer screening tests for patients. The US Preventive Services Task Force (USPSTF) recommends screening for colorectal cancer starting at 50 years of age to 75 years of age in the US as a means of preventing disease incidence and ensuring early-stage treatment. Canada has also implemented guidelines for biennial colorectal cancer screening for people aged 50 to 74 years.

MarketsandMarkets™ View on Revenue: The global cancer diagnostics market size was valued at USD 17.2 billion in 2021 and is expected to grow at a CAGR of 11.5%

Industry Segmentation in Detailed:

The consumables segment is expected to grow at the highest CAGR during the forecast period.

Based on the product, the cancer diagnostics market is segmented into consumables and instruments. The consumables segment is projected to witness the highest growth during the forecast period. The repeated purchase and high consumption, and the high prevalence of diseases the major factors supporting the growth of this segment.

The technology segment accounted for the largest share of the cancer diagnostics market.

By technology, the cancer diagnostics market is segmented IVD testing, imaging based and biopsy technique. The IVD testing segment accounted for the largest market share in 2020. The large share of this segment can be attributed to increasing incidence of cancer.

Hospitals for the largest share of the cancer diagnostics market.

Based on end-users, the cancer diagnostics market is segmented into hospitals and diagnostic laboratories. The hospitals segment accounted for the largest share of the cancer diagnostics market in 2020. The increasing number of patients visiting hospitals, rising number of in-house diagnostic procedures performed in hospitals, and growing awareness regarding early diagnosis is are the major driving factor for this market.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=186559121

Leading Key Players Analysis:

Some of the major players operating in this market are GE Healthcare (US), Roche Diagnostics (Switzerland), and Becton, Dickinson and Company (US). In 2020, GE Healthcare held the leading position in the market. The company has a strong geographic presence across the US, Asia, Europe, Middle East and Africa, & the Americas. Moreover, the company’s strong brand recognition and comprehensive product portfolio in the cancer diagnostics market is its key strength. BD held the second position in the cancer diagnostics market in 2020.

Geographical Trends in Detailed:

The cancer diagnostics market is segmented into four major regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World. In 2020, North America accounted for the largest share of the cancer diagnostics market. The large share of North America can be attributed to factors such as the increasing incidences of cancer, growing awareness early diagnosis and technological advancement.

Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=186559121

April 26, 2022 0

Single cell Analysis Market Size, Share, Growth, Trend, and Forecast

According to the new market research report “Single cell Analysis Market by Product (Consumables and Instruments), Cell Type (Human and Animal), Technique (Flow Cytometry, NGS, PCR, and Mass Spectrometry), Application (Cancer, Neurology, NIPD, IVF, and CTCs), End User — Global Forecast”, published by MarketsandMarkets™, The single cell analysis market is expected to reach $ 3.59 Billion, at a CAGR of 16.5%

Read a Press Release on “Single cell Analysis Market”

https://www.marketsandmarkets.com/PressReleases/single cell-analysis.asp

Consumables estimated to dominate the market in 2017

Based on the type of products, the single cell analysis market is segmented into consumables and instruments. The consumables segment is expected to dominate this market, primarily due to the requirement of frequent and repeat purchase of these products as compared to instruments, which are considered as a one-time investment.

Browse and in-depth TOC on “Single cell Analysis Market”

107 — Tables

42 — Figures

175 — Pages

Flow cytometry to have the largest market share in 2017

On the basis of technique, the single cell analysis market is segmented into flow cytometry, NGS, PCR, microscopy, mass spectrometry, and other techniques (including single-molecule fluorescence in situ hybridization, micromanipulation, and automated capillary electrophoresis). In 2017, flow cytometry is expected to dominate the market. Wide usage of flow cytometry in single cell analysis applications is expected to boost the demand for single cell analysis techniques.

North America to dominate the market followed by Europe

On the basis of the region, the single cell analysis market is segmented into North America, Europe, Asia, and RoW. In 2017, North America accounted for the largest share of the market, followed by Europe. The large share of the North American market is attributed to the factors such as increasing collaborations among prominent players, technological advancements, and expanding biotechnology and pharmaceutical industries. Factors such as increasing incidence of diseases, government support for various research activities, and growing focus on stem cell research and regenerative medicine are expected to fuel the market growth in the European region.

The single cell analysis market is highly competitive with the presence of major players. Merck KGaA (Germany), Becton, Dickinson and Company (U.S.), Promega Corporation (U.S.), Danaher Corporation (U.S.), General Electric Company (U.K.), Thermo Fisher Scientific Inc. (U.S.), Miltenyi Biotec (Germany), Illumina, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Fluidigm Corporation (U.S.), NanoString Technologies, Inc. (U.S.)

Know more about key industry players:

https://www.marketsandmarkets.com/ResearchInsight/single cell-analysis-market.asp

June 14, 2019 0

Rehabilitation Equipment|Geographical Growth|Opportunities|Key Players

Rehabilitation Equipment Market growth can be attributed to factors such as increased incidence of disabilities resulting from non-communicable diseases, favorable healthcare reforms, and rapid growth in the geriatric population coupled with the rising prevalence of chronic diseases. However, a high cost & maintenance expense of rehabilitation equipment is the key factor that is expected to restrain the growth of this market to a certain extent.

Expected Growth For Rehabilitation Equipment Market:

The global rehabilitation equipment market is projected to reach USD 14.91 billion, at a CAGR of 8.6%

Geographical Growth and Opportunities Scenario?

The market is dominated by Europe, followed by North America, Asia, and the Rest of the World. In 2016, Europe accounted for the largest share of the global rehabilitation equipment market. North America is expected to grow at the highest CAGR during the forecast period. Factors such as growth in the geriatric population and the subsequent increase in the prevalence of lifestyle diseases and the presence of favorable healthcare reforms are driving the growth of the North American rehabilitation equipment.

Major Market Developments:

In Febuiary 2017, Invacare upgraded the K series of its pioneering brand Küschall. The new active chair Küschall Champion SK is a sleek, smart, and lightweight folding wheelchair.
In December 2016, Medline partnered with ViaQuest, Inc. (U.S.) to deliver ViaQuest Home Health and Hospice patient supplies across Indiana, Ohio, and Pennsylvania.
In January 2017, Drive DeVilbiss Healthcare acquired Sidhil Group Limited (U.K.), a leading provider to homecare, acute care, and long-term care settings. This acquisition will expand Drive’s existing manufacturing capabilities in the U.K. while adding significant manufacturing expertise to the European platform.

Major Market Key Players in Rehabilitation Equipment Market:

Some of the prominent players in this market are Invacare Corporation (US), Medline Industries, Inc. (US), Dynatronics Corporation (US), Drive DeVilbiss Healthcare (US), Changzhou Qian Jing Rehabilitation Co., Ltd. (China), Carex Health Brands (US), Roma Medical (U.K.), Caremax Rehabilitation Equipment Co. Ltd. (China), GF Health Products, Inc. (US), and Hospital Equipment Manufacturing Company (India).

Biobanking Market by Product and Service – Global Forecast to 2022

The global market is segmented by product and service, sample type, storage type, application, and regions. By-product and service, the market are segmented into equipment, consumables, services, and software. The equipment segment is expected to lead the global market in 2017. Factors such as the growth in the number of biobanks and number of biosamples to be stored are increasing the demand for biobanking equipment.

Expected Growth For Biobanking Market – The Biobanking Market is expected to reach USD 2.69 Billion, at a CAGR of 7.8%.

Geographical Growth And Opportunities Scenario?

The global market is dominated by North America, followed by Europe. North America will continue to dominate the global market in the forecast period. However, Asia-Pacific is expected to witness the highest CAGR, with the growth in this market centered at Japan, China, and India. Improving life sciences research infrastructure in emerging economies and growing government investment in biomedical, pharmaceutical, and biotechnology industries are some of the factors propelling market growth in the Asia-Pacific region.

Sample Report Available – https://www.marketsandmarkets.com/requestsampleNew.asp?id=594

The objectives Covered in this research study?

To define, describe, and forecast the market by product and service, sample type, storage type, application, and region
To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)
To analyze micro-markets with respect to individual growth trends, prospects, and contributions to the overall market
To analyze the opportunities in the market for stakeholders and provide details of a competitive landscape for market leaders
To forecast revenue of the market segments with respect to four main regional segments, namely, North America, Europe, Asia-Pacific, and the Rest of the World (RoW)
To profile key players and comprehensively analyze their market shares and core competencies in terms of market development and growth strategies

Major Market Key Players in Biobanking Market?

Thermo Fisher Scientific Inc. (U.S.), Tecan Group Ltd. (Switzerland), Qiagen N.V. (Germany), Hamilton Company (U.S.), Brooks Automation (U.S.), TTP Labtech Ltd (U.K.), VWR Corporation (U.S.), Promega Corporation (U.S.), Worthington Industries [(Taylor Wharton, U.S.)], Chart Industries (U.S.), Becton, Dickinson and Company (U.S.), Merck KGaA (Germany), Micronic (Netherlands).

January 11, 2019 0